captisol-enabled budesonide + azelastine (LGD-313)
/ Ligand
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 24, 2020
Comparison of Montelukast and Azelastine in Treatment of Moderate to Severe Allergic Rhinitis
(clinicaltrials.gov)
- P=N/A; N=66; Recruiting; Sponsor: Shiraz University of Medical Sciences
New trial • Allergic Rhinitis • Immunology
1 to 1
Of
1
Go to page
1